Compounds > nemonapride
Page last updated: 2024-10-31

nemonapride and Idiopathic Parkinson Disease

nemonapride has been researched along with Idiopathic Parkinson Disease in 1 studies

N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide : A benzamide obtained by formal condensation of the carboxy group of 5-chloro-2-methoxy-4-(methylamino)benzoic acid with the amino group of 1-benzyl-2-methylpyrrolidin-3-amine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seeman, P1
Guan, HC1
Van Tol, HH1
Niznik, HB1

Other Studies

1 other study available for nemonapride and Idiopathic Parkinson Disease

ArticleYear
Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Synapse (New York, N.Y.), 1993, Volume: 14, Issue:4

    Topics: Animals; Benzamides; Corpus Striatum; Dopamine D2 Receptor Antagonists; Humans; In Vitro Techniques;

1993